article thumbnail

What to expect from PEGS Europe 2023: Day 1

Drug Discovery World

Optimising drug properties This session will begin with chairperson’s remarks from Andreas Evers, PhD, Principal Scientist, Computational Chemistry & Biology, Global Research & Development Discovery Technology, Merck Healthcare KGaA. CCO & Co-Founder, ATUM, on: “Using machine learning to predict protein expression”.